HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Arthralgia (Joint Pain)

Pain in the joint.
Also Known As:
Joint Pain; Joint Pains; Arthralgias; Pain, Joint; Pains, Joint; Polyarthralgias; Polyarthralgia
Networked: 2598 relevant articles (212 outcomes, 190 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pain (Aches)
2. Fever (Fevers)
3. Osteoarthritis
4. Fatigue
5. Headache (Headaches)

Experts

1. van Schaardenburg, Dirkjan: 12 articles (12/2015 - 01/2010)
2. Mao, Jun J: 10 articles (08/2015 - 08/2009)
3. DeMichele, Angela: 8 articles (01/2015 - 06/2009)
4. McDougall, Jason J: 8 articles (01/2014 - 05/2006)
5. Ng, Lisa F P: 6 articles (08/2015 - 01/2011)
6. Hershman, Dawn L: 6 articles (06/2015 - 09/2007)
7. Huizinga, Tom W J: 6 articles (01/2015 - 04/2013)
8. Farrar, John T: 6 articles (12/2014 - 06/2009)
9. van de Stadt, Lotte A: 5 articles (01/2015 - 01/2010)
10. Xie, Sharon X: 5 articles (12/2014 - 06/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Arthralgia:
1. Prednisolone (Predate)FDA LinkGeneric
2. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
3. C-Reactive ProteinIBA
10/01/1998 - "Among completers (54 and 34 patients, respectively), significant improvement compared to baseline was noted in all seven clinical variables (morning stiffness, overall joint pain, count of tender/swollen joints, Lansbury articular score, functional score and grip strength), ESR and C-reactive protein without significant intergroup differences. "
01/01/2000 - "Statistically significant differences were found only for arthralgia (P=0.026) and elevated concentration of C-reactive protein (P=0.003); both variables were found more often in patients with acute HGE. "
10/01/2011 - "After one year's treatment with the S-15 column, the β2-m level decreased from 29.3±9.6mg/L to 24.7±5.1mg/L (P<0.05), and the high sensitive C-reactive protein level decreased from 2996±4380ng/mL to 1292±1774ng/mL. After one year of S-15 column use, pinch strength increased from 5.9±3.0pounds to 7.2±3.2pounds (P<0.05), and the visual analog scale for joint pain and activities of daily living score also improved. "
01/01/2015 - "Standard data collected included demographic data, erythrocyte sedimentation rate, C-reactive protein, clinical measures of disease activity (Disease Activity Score in 28 joint counts [DAS28], Clinical Disease Activity Index [CDAI], Simplified Disease Activity Index [SDAI] and global assessments) and patient-reported outcomes (measures of physical function, joint pain, fatigue, patient global assessment and morning stiffness). "
01/01/2014 - "Among the ACPA-negative arthralgia patients, MRI inflammation scores were related to C-reactive protein (CRP) levels and the tenderness of scanned joints. "
4. SteroidsIBA
5. Analgesics (Analgesic Drugs)IBA
6. Hyaluronic Acid (Hyaluronan)IBA
7. Glucosamine (Dona)IBA
8. Botulinum Toxins (Botulinum Toxin)IBA
9. Prednisone (Sone)FDA LinkGeneric
10. TNFR-Fc fusion protein (etanercept)FDA Link

Therapies and Procedures

1. Aftercare (After-Treatment)
2. Drug Therapy (Chemotherapy)
3. Intra-Articular Injections
4. Activities of Daily Living (ADL)
5. Splints